#6 - Ozempic and Beyond: Changing Tides in Health, Society, and Industry

12/27/23 • 70 min

Join us on "The Gustavo Franco Podcast" for a riveting exploration of Ozempic and other GLP-1 drugs, which are reshaping more than just diabetes and obesity treatment. This episode ventures beyond healthcare, revealing the profound impact of these drugs on society, economy, and even fashion and fast food industries. Engage with us as we unravel the ethical debates and lifestyle transformations stemming from this pharmaceutical phenomenon. Don't miss the chance to discover the extensive influence of Ozempic and GLP-1 drugs in an episode packed with intriguing and insightful discussions.

Researched and produced by Brian Li.

Timestamps:

(00:00:00) - Channel Intro

(00:02:00) - Episode Introduction

(00:04:41) - GLP-1 Drugs

(00:07:16) - Biology

(00:09:39) - Pharmaceutical Development

(00:15:17) - Rise to Fame

(00:18:19) - Growth of Industry

(00:20:14) - Ozempic’s Dual Use

(00:22:02) - Wegovy for Obesity

(00:24:10) - Introducing Zepbound

(00:25:23) - Off-Label Use

(00:27:10) - Accessibility and Inequality

(00:29:02) - Employer and Government Initiatives to Improve Access

(00:31:08) - Impact on Industry: Fast Food, Fashion, Air Travel

(00:40:28) - Obesity Spending

(00:42:44) - Economic Implications in Healthcare

(00:44:56) - Medical Technology and Dieting Industries

(00:48:03) - Healthcare System: Good or Bad?

(00:50:31) - Health Paradigm Shift

(00:52:43) - Exacerbating Social Inequalities

(00:54:05) - Ethical Considerations: Root Causes, Dependency, Side Effects, Long Term Risks, Children, Consent, Autonomy, Marketing

(01:04:47) - Addiction Potential

(01:06:55) - Conclusion

(01:09:10) - Outro

Linktree: linktr.ee/gustavofrancopod

Researched and produced by Brian Li.

Timestamps:

(00:00:00) - Channel Intro

(00:02:00) - Episode Introduction

(00:04:41) - GLP-1 Drugs

(00:07:16) - Biology

(00:09:39) - Pharmaceutical Development

(00:15:17) - Rise to Fame

(00:18:19) - Growth of Industry

(00:20:14) - Ozempic’s Dual Use

(00:22:02) - Wegovy for Obesity

(00:24:10) - Introducing Zepbound

(00:25:23) - Off-Label Use

(00:27:10) - Accessibility and Inequality

(00:29:02) - Employer and Government Initiatives to Improve Access

(00:31:08) - Impact on Industry: Fast Food, Fashion, Air Travel

(00:40:28) - Obesity Spending

(00:42:44) - Economic Implications in Healthcare

(00:44:56) - Medical Technology and Dieting Industries

(00:48:03) - Healthcare System: Good or Bad?

(00:50:31) - Health Paradigm Shift

(00:52:43) - Exacerbating Social Inequalities

(00:54:05) - Ethical Considerations: Root Causes, Dependency, Side Effects, Long Term Risks, Children, Consent, Autonomy, Marketing

(01:04:47) - Addiction Potential

(01:06:55) - Conclusion

(01:09:10) - Outro

Linktree: linktr.ee/gustavofrancopod

Previous Episode

#5 - Dr. Christopher King: Addressing Systemic Racism in Healthcare

Dr. Christopher King is the inaugural Dean of Georgetown University’s School of Health and an associate professor whose work focuses on healthcare, public health, and racial justice. With over 20 years of experience in the healthcare sector, Dr. King is a nationally recognized speaker on achieving equitable systems of care.

In this episode, Dr. King helps me navigate the complex terrain of racial inequalities in healthcare. We dissect systemic racism's deep-seated roots, from institutional biases to the pressing crisis of maternal mortality among African American women. Dr. King takes me through history to understand how past injustices shape today’s healthcare landscape, especially in the context of COVID-19 and Washington, D.C. He brings forward groundbreaking strategies to dismantle these disparities, focusing on atonement, diversity in the medical workforce, and the crucial role of public awareness. We conclude with a forward-looking discussion on how philanthropy, technology, and AI might reshape the pursuit of racial equality in healthcare.
Timestamps:

(00:00:00) Channel Intro

(00:02:00) Episode Intro

(00:05:40) Defining Race in Healthcare

(00:16:15) Defining Racism: Institutionalized, Personally-mediated, and Internalized

(00:26:19) Evidence: Maternal Mortality and Cancer

(00:32:50) Historical Context: Slavery, Jim Crow Era, Immigration, Eugenics, Sterilizations, Tuskegee Study, and Henrietta Lacks

(00:50:57) COVID-19 and Reconceptualizing Race

(00:54:50) Disparities in Washington D.C.

(01:04:00) Proximity to Black

(01:06:40) Medical Errors

(01:08:36) Tackling Racial Inequalities: Atonement, Measuring Racism, Workplace Diversity, and Awareness

(01:21:54) Philanthropy, Narcissism, and Social Media

(01:28:11) Artificial Intelligence

(01:31:04) Outro

Linktree: linktr.ee/gustavofrancopod

Next Episode

Welcome to The Gustavo Franco Podcast

Welcome to your favorite healthcare podcast! We explore the multifaceted healthcare system in the United States, compare it to other countries, and discuss new solutions to healthcare issues.

Linktree: linktr.ee/gustavofrancopod

The Gustavo Franco Podcast - #6 - Ozempic and Beyond: Changing Tides in Health, Society, and Industry

Transcript

Ozempic and Beyond: Changing Tides in Health, Society, and Industry

Introduction

Welcome to a new episode of the Gustavo Franco Podcast. Today, we delve into a topic that's creating ripples across the healthcare landscape and beyond – the world of GLP-1 agonists, with a spotlight on Ozempic. Semaglutide, commercially known as Ozempic, was introduced by Novo Nordisk in the United States market in 2017, marking a significant breakthrough in